We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,244

Obviousness only requires reasonable expectation of success of one compound encompassed by broad genus claims
  • McDermott Will & Emery
  • USA
  • July 30 2014

Addressing the issue of showing a reasonable expectation of success when making obviousness combinations in the context of broad genus claims, the U


A compound is obvious where only minor changes to a prior art “lead compound” are required to make the claimed compound
  • McDermott Will & Emery
  • USA
  • July 30 2014

Addressing the obviousness of a claimed compound where a person of skill would need to make only minor changes to a lead compound to arrive at the


A combination of references need only provide a “reasonable expectation of success”
  • McDermott Will & Emery
  • USA
  • May 29 2014

Addressing the validity of a dosing regimen patent in Abbreviated New Drug Application (ANDA) litigation, the U.S. Court of Appeals for the Federal


Contractual duty to deal does not equal antitrust duty to deal
  • McDermott Will & Emery
  • USA
  • July 30 2014

Addressing for the first time whether a patent holder under a contractual duty to deal is also subject to an antitrust duty to deal, the U. S. Court


Il Food Safety Modernization Act (FSMA), l’FDA e la rilevanza per I produttori alimentari italiani
  • McDermott Will & Emery
  • Italy, USA
  • August 4 2014

Il mercato statunitense è indubbiamente ancora un mercato, per dimensioni, ricchezza e qualità, tra i più ambiti (anche) per il settore alimentare


Just in time for the holidays: another HIPAA settlement
  • McDermott Will & Emery
  • USA
  • December 11 2014

On December 2, 2014, the Office for Civil Rights (OCR) and Anchorage Community Mental Health Services, Inc., (ACMHS) entered into a Resolution


If written description matches claim scope, no 112 problem
  • McDermott Will & Emery
  • USA
  • March 31 2014

The U.S. Court of Appeals for the Federal Circuit affirmed a district court rejection of a written description challenge to patentability, concluding


Employer shared responsibility payments and reporting requirements under the Affordable Care Act: Code Sections 6055 and 6056
  • McDermott Will & Emery
  • USA
  • September 13 2014

There are two types of employer shared responsibility payments, also known as pay or play penalties, under the Affordable Care Act (ACA). The first


Closely held corporations can be exempt from ACA contraception provisions based on religious objections
  • McDermott Will & Emery
  • USA
  • July 2 2014

The Patient Protection and Affordable Care Act (ACA) requires certain employers to cover women’s preventive health care under their nongrandfathered


CMS again delays implementation of controversial “2 Midnights Rule"
  • McDermott Will & Emery
  • USA
  • February 4 2014

Hospitals gearing up for implementation of the "2 Midnights Rule" have more time to prepareor consider joining efforts to modify or rescind the